Search

Search Constraints

You searched for: Author/Creator Brouwer, Rolf E.

Search Results

2. Rituximab‐PECC induction followed by 90Y‐ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study. (10th July 2019)